J&J Harnessing Pharma Business Advantages For Global OTC Growth
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's consumer products division is leveraging the capabilities of its prescription pharmaceutical business infrastructures to grow its "iconic brands" and create new products
You may also be interested in...
J&J Sees Opportunities In Wellness Under Health Care Reform
Johnson & Johnson sees multiple business opportunities in the Obama administration's emphasis on wellness and prevention as part of its health care reform agenda
Sea Changes In Regulation And The Market: Top Stories Of 2008
When an iconic drug brand drew scrutiny on Capitol Hill for possibly violating FDA's policy against combinations of drugs and dietary supplements, OTC and supplement interests took notice
Managed Care Influences OTC Switch With Zyrtec As Model – Nielsen
Data not only show some consumers are choosing OTC Zyrtec over other nonprescription allergy drugs they previously used, but also that managed-care plans have growing influence on OTC choices, according to Nielsen market research firm executive Matt Dumas